Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03592771 · ClinicalTrials.gov registry record · NA

THRIVE Breast Cancer App Study

A NA study of Breast Neoplasm Female, sponsored by Emory University.

Completed
Registry status
NA
Development phase
304
Enrollment target
2
Study locations

NCT03592771 is a NA study of Breast Neoplasm Female that has completed, run by Emory University. The registered enrollment target is 304 participants, above the 142-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (114% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03592771, a NA study of Breast Neoplasm Female, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
304 participants
Enrollment target
2
Study locations

Study Summary

This study will test the use of a web-enabled app that is integrated directly with patients' electronic health records, with and without tailored feedback. The app-based intervention is designed to improve patient-provider communication outside of clinic visits, resulting in improved symptom management and adjuvant endocrine therapy adherence among diverse patients with hormone receptor-positive breast cancer. The researchers will evaluate the impact of the intervention on a comprehensive set of outcomes, including rigorous measures of long-term adherence, quality of life, and costs.

Conditions Studied

Breast Neoplasm Female

Interventions

  • BEHAVIORAL THRIVE App
  • BEHAVIORAL Tailored Feedback Messages

Study Locations (2)

Tennessee

  • West Cancer Center, Midtown - Memphis
  • West Cancer Center, East Memphis - Memphis

Trial Details

FieldValue
Enrollment Target 304 participants
Start Date 2018-11-15
Est. Completion 2022-06-30
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03592771

The ClinicalTrials.gov registry entry for NCT03592771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 142-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (114% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Neoplasm Female appearing as the primary indexed condition, and to 2 interventions - of which THRIVE App is the first listed.

NCT03592771 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03592771 about?

NCT03592771 is a clinical study titled "THRIVE Breast Cancer App Study". This study will test the use of a web-enabled app that is integrated directly with patients' electronic health records, with and without tailored feedback. The app-based intervention is designed to improve patient-provider communication outside of clinic visits, resulting in improved symptom managem...

What is the current status of trial NCT03592771?

This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2018-11-15. Estimated completion is 2022-06-30.

What conditions does trial NCT03592771 study?

This clinical trial studies the following conditions: Breast Neoplasm Female.

What interventions are being tested in trial NCT03592771?

The interventions under investigation include: THRIVE App (BEHAVIORAL), Tailored Feedback Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT03592771?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03592771 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Neoplasm Female

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Neoplasm Female

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.